Theralase Technologies Inc. V.TLT

Treatment Cost

[Camphikefish]

Hi everyone, I read today that Alstiladrin treatment is expected to fall roughly between 160k and 260k per patient. 80,000 new cases per year in the US makes it a total opportunity of 1.2 billion using 160k as a multiplier. 25% of that is a realistic 300 million in sales revenue and a fair target number for 1433. Does anyone know the math from here? In orthopedics the somewhat historical buyout number has been 6 X annual sales give or take. These are US numbers alone so we could be worth 1.8 billion easily however, I realize we all believe we're worth far more. Wonder what we would be worth with worldwide numbers included? Curious again what others believe we will be bought for just for fun.

[frebeach1]

Way back at the time when they were testing with mice, the charging expectation was $50,000 per Canadian patient and not charging so much to be only a remedy for the richest people, assuming we kept this technology access for all Canadians regardless of whether they are rich or poor. Dave at Bare Oaks. Canada.

[consultant99]

 80,000 cases x $160,000/case = $12.8 Billion likly 10-25% sales potential puts annual revenues between $1.28 and $3.2 billion

[Camphikefish]

My fault consultant99. Night time mistake and bad math. No harm intended. And to Gojo peace to you. I'm no social engineer Mr. know it all. I'm a guy who wants to make a 5000 multiple just like you. People on this board have made predictions through the 10 years, yes 10 years I've been here. You have no earthly concept of who I am Mr. Intellectual. 3 figures. Really? I'm 55 years

[Tapps21]

I'm in the same boat Camp. Kudos to you. 30 plus years of working Canadian winters. Been real long here and $15-20 would be life changing for the remainder of it. Im not greedy. Good luck to all of us. I would love a meet and greet in Vegas one day (soon), fingers crossed. 

[frebeach1]

Where did you get 80,000 patient number? How many people have $160,000 disposable income? Dave

[skys1]

True frebeach, most don't have a spare $160K to spend on the treatment but insurance companies do. However because it is much less expensive than other treatments, insurance companies will pick up the coverage because it will actually save them money.

[Rumpl3StiltSkin]

I think Alstiladrin is going to make $Zilch.. Per patient. The reason I think that is TLT and 1433 could beat them to market. Yes they are FDA approved but as CancerSlayer has mentioned. They still have a few hoops to jump through before they can start selling it. So I think 1433 could be somewhere closer to their lower price point per patient, so a higher cost per dose, yet still very copetitive